Probiotic lactobacillus reuteri has antifungal effects on oral Candida species in vitro

Journal of Oral Microbiology

Volumn 9, Issue 1, 2017, Pages

  Jørgensen, Mette Rose ^a   Kragelund, Camilla ^a   Jensen, Peter Østrup ^b   Keller, Mette Kirstine ^a   Twetman, Svante ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

Antimycotic; Beneficial bacteria; Candidiasis; Co aggregation; Growth inhibition; Yeast

Indexed keywords

ANTIFUNGAL AGENT; HYDROGEN PEROXIDE; PROBIOTIC AGENT;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; DRUG SCREENING; GROWTH INHIBITION; IN VITRO STUDY; LACTOBACILLUS REUTERI; NONHUMAN; PH; PICHIA KUDRIAVZEVII; SPECTROPHOTOMETRY;

EID: 85015052117     PISSN: None     EISSN: 20002297     Source Type: Journal    
DOI: 10.1080/20002297.2016.1274582     Document Type: Article

References (40)

1. Barros PP, Ribeiro FC, Rossoni RD, et al. Influence of Candida krusei and Candida glabrata on Candida albicans gene expression in in vitro biofilms. Arch Oral Biol. 2016;64:92-101.
2. Sardi JC, Scorzoni L, Bernardi T, et al. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62:10-24.
3. Kragelund C, Kieffer-Kristensen L, Reibel J, et al. Oral candidosis in lichen planus: the diagnostic approach is of major therapeutic importance. Clin Oral Investig. 2013;17:957-965.
4. Matsubara VH, Bandara HM, Mayer MP, et al. Probiotics as antifungals in mucosal candidiasis. Clin Infect Dis. 2016;62:1143-1153.
5. Laleman I, Teughels W. Probiotics in the dental practice: a review. Quintessence Int. 2015;46:255-264.
6. Sanders ME. Probiotics: definition, sources, selection, and uses. Clin Infect Dis. 2008;46(Suppl 2):S58-S61; discussion S144-S151.
7. Jorgensen MR, Keller MK, Kragelund C, et al. Lactobacillus reuteri supplements do not affect salivary IgA or cytokine levels in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over trial. Acta Odontol Scand. 2016;74:399-404.
8. Oever JT, Netea MG. The bacteriome-mycobiome interaction and antifungal host defense. Eur J Immunol. 2014;44:3182-3191.
9. Valeur N, Engel P, Carbajal N, et al. Colonization and immunomodulation by Lactobacillus reuteri ATCC in the human gastrointestinal tract. Appl Environ Microbiol. 2004;70:1176-1181.
10. Cleusix V, Lacroix C, Vollenweider S, et al. Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria. BMC Microbiol. 2007;7:101.
11. Kraft-Bodi E, Jorgensen MR, Keller MK, et al. Effect of probiotic bacteria on oral Candida in frail elderly. J Dent Res. 2015;94:181S-6S.
12. Collado MC, Meriluoto J, Salminen S. Adhesion and aggregation properties of probiotic and pathogen strains. Eur Food Restechnol. 2008;226:1065-1073.
13. Twetman L, Larsen U, Fiehn NE, et al. Coaggregation between probiotic bacteria and caries-associated strains: an in vitro study. Acta Odontol Scand. 2009;67:284-288.
14. Keller MK, Hasslof P, Stecksen-Blicks C, et al. Coaggregation and growth inhibition of probiotic lactobacilli and clinical isolates of mutans streptococci: an in vitro study. Acta Odontol Scand. 2011;69:263-268.
15. Saha S, Tomaro-Duchesneau C, Rodes L, et al. Investigation of probiotic bacteria as dental caries and periodontal disease biotherapeutics. Benef Microbes. 2014;5:447-460.
16. Kohler GA, Assefa S, Reid G. interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans. Infect Dis Obstet Gynecol. 2012;2012:1-14. DOI:10.1155/2012/636474
17. Strus M, Kucharska A, Kukla G, et al. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect Dis Obstet Gynecol. 2005;13:69-75.
18. Hasslof P, Hedberg M, Twetman S, et al. Growth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli-an in vitro study. BMC Oral Health. 2010;10:18.
19. Coman MM, Verdenelli MC, Cecchini C, et al. In vitro evaluation of antimicrobial activity of Lactobacillus rhamnosus IMC 501(R), Lactobacillus paracasei IMC 502(R) and SYNBIO(R) against pathogens. J Appl Microbiol. 2014;117:518-527.
20. Verdenelli MC, Coman MM, Cecchini C, et al. Evaluation of antipathogenic activity and adherence properties of human Lactobacillus strains for vaginal formulations. J Appl Microbiol. 2014;116:1297-1307.
21. Chew SY, Cheah YK, Seow HF, et al. Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates. J Appl Microbiol. 2015;118:1180-1190.
22. Angeletti S, Lo Presti A, Cella E, et al. Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) and Bayesian phylogenetic analysis to characterize Candida clinical isolates. J Microbiol Methods. 2015;119:214-222.
23. Simark-Mattsson C, Emilson CG, Hakansson EG, et al. Lactobacillus-mediated interference of mutans streptococci in caries-free vs. caries-active subjects. Eur J Oral Sci. 2007;115:308-314.
24. Kolpen M, Appeldorff CF, Brandt S, et al. Increased bactericidal activity of colistin on Pseudomonas aeruginosa biofilms in anaerobic conditions. Pathog Dis. 2016;74. DOI:10.1093/femspd/ftv086
25. Kang MS, Oh JS, Lee HC, et al. Inhibitory effect of Lactobacillus reuteri on periodontopathic and cariogenic bacteria. J Microbiol. 2011;49:193-199.
26. Ryan CS, Kleinberg I. Bacteria in human mouths involved in the production and utilization of hydrogen peroxide. Arch Oral Biol. 1995;40:753-763.
27. Jenkinson HF, Lala HC, Shepherd MG. Coaggregation of Streptococcus sanguis and other streptococci with Candida albicans. Infect Immun. 1990;58:1429-1436.
28. Jiang Q, Stamatova I, Kari K, et al. Inhibitory activity in vitro of probiotic lactobacilli against oral Candida under different fermentation conditions. Benef Microbes. 2015;6:361-368.
29. Zhao C, Lv X, Fu J, et al. In vitro inhibitory activity of probiotic products against oral Candida species. J Appl Microbiol. 2016;121:254-262.
30. Eschenbach DA, Davick PR, Williams BL, et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol. 1989;27:251-256.
31. Halm M, Hornbaek T, Arneborg N, et al. Lactic acid tolerance determined by measurement of intracellular pH of single cells of Candida krusei and Saccharomyces cerevisiae isolated from fermented maize dough. Int J Food Microbiol. 2004;94:97-103.
32. Vylkova S, Carman AJ, Danhof HA, et al. The fungal pathogen Candida albicans autoinduces hyphal morphogenesis by raising extracellular pH. MBio. 2011;2:e00055-e00011.
33. Buffo J, Herman MA, Soll DR. A characterization of pH-regulated dimorphism in Candida albicans. Mycopathologia. 1984;85:21-30.
34. Holyoak CD, Stratford M, McMullin Z, et al. Activity of the plasma membrane H+-ATPase and optimal glycolytic flux are required for rapid adaptation and growth of Saccharomyces cerevisiae in the presence of the weak-acid preservative sorbic acid. Appl Environ Microbiol. 1996;62:3158-3164.
35. Zikanova B, Kuthan M, Ricicova M, et al. Amino acids control ammonia pulses in yeast colonies. Biochem Biophys Res Commun. 2002;294:962-967.
36. Ahola AJ, Yli-Knuuttila H, Suomalainen T, et al. Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors. Arch Oral Biol. 2002;47:799-804.
37. Cagetti MG, Mastroberardino S, Milia E, et al. The use of probiotic strains in caries prevention: a systematic review. Nutrients. 2013;5:2530-2550.
38. Caglar E, Topcuoglu N, Cildir SK, et al. Oral colonization by Lactobacillus reuteri ATCC 55730 after exposure to probiotics. Int J Paediatr Dent. 2009;19:377-381.
39. Ramirez-Quijas MD, Lopez-Romero E, Cuellar-Cruz M. Proteomic analysis of cell wall in four pathogenic species of Candida exposed to oxidative stress. Microb Pathog. 2015;87:1-12.
40. Costa-de-Oliveira S, Sampaio-Marques B, Barbosa M, et al. An alternative respiratory pathway on Candida krusei: implications on susceptibility profile and oxidative stress. FEMS Yeast Res. 2012;12:423-429.